# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-010789
Filing Date
2025-08-07
Accepted
2025-08-07 16:31:13
Documents
66
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | acrs-20250630x10q.htm iXBRL | 10-Q | 1962170
2 | EX-31.1 | acrs-20250630xex31d1.htm | EX-31.1 | 15491
3 | EX-31.2 | acrs-20250630xex31d2.htm | EX-31.2 | 15556
4 | EX-32.1 | acrs-20250630xex32d1.htm | EX-32.1 | 9427
| Complete submission text file | 0001558370-25-010789.txt |  | 8491435

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | acrs-20250630.xsd | EX-101.SCH | 45023
6 | EX-101.CAL | acrs-20250630_cal.xml | EX-101.CAL | 44084
7 | EX-101.DEF | acrs-20250630_def.xml | EX-101.DEF | 184703
8 | EX-101.LAB | acrs-20250630_lab.xml | EX-101.LAB | 442593
9 | EX-101.PRE | acrs-20250630_pre.xml | EX-101.PRE | 303079
69 | EXTRACTED XBRL INSTANCE DOCUMENT | acrs-20250630x10q_htm.xml | XML | 1834669

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37581 | Film No.: 251194687
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)